Danirixin Dose Ranging Study in Participants With Chronic Obstructive Pulmonary Disease (COPD)

NCT03034967 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

614

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG: Danirixin
DRUG: Danirixin matching placebo
DRUG: Standard of care
DRUG: Rescue medication

Sponsor

GlaxoSmithKline